TRENDING :  Market Movers  |  Top 50   AAPL (0.65%)    TSLA (-1.01%)    AA (3.66%)    RIOT (12.32%)    QURE (2.45%)    QQQ (-0.02%)    QCOM (0.85%)    PSTG (-0.21%)    PEI (-2.21%)    PAH (0%)    MDB (0.47%)    MCD (0.7%)    KO (0.61%)    JPM (0.49%)    IVC (4.72%)    GS (-0.04%)    GH (0.38%)    FUV (-7.64%)    FCEL (17.49%)    FB (0.17%)    EA (-4.21%)    CRM (-1.29%)    CBS (1.25%)    BILI (2.87%)    BIDU (-0.74%)


$362.25 [2.88][0.81%]

Next Earnings



Trade Idea »


Quarterly Rating Chart


1=Strong Buy, 2=Buy, 3=Hold, 4=Underperform, 5=Sell
Price Targets
High $461.00
Low $461.00
Average $461.00
Current $362.25

CompanyAnalyst NamePT ActionActionRatingTargetDate
Morgan StanleyLowersMaintainsStrong Buy$461.0001/02/19
*Last 90 days


No recommendations found.
Service NameTrader NameStrategy% ReturnIssue Date
TopFlight Trades - Premium (Options)Eric CunninghamBuy Calls-10.00 %02/13/19View

This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.



Analysts Predict 15% Gains Ahead For The Holdings of SPHB

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the

Has ABIOMED (ABMD) Outpaced Other Medical Stocks This Year?

The Medical group has plenty of great stocks but investors should always be looking for companies that are outperforming their peers Is ABIOMED ABMD one of those stocks right now By taking a look at the stock s year to date performance in comparison to its Medical peers we might be able

Top Ranked Momentum Stocks to Buy for February 11th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today February 11th Apartment Investment and Management Company AIV This real estate investment trust has a Zacks Rank 2 Buy and witnessed the Zacks Consensus Estimate for its current

Top Ranked Momentum Stocks to Buy for February 6th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today February 6th Allegiant Travel Company ALGT This leisure travel company has a Zacks Rank 2 Buy and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16

Why Pitney Bowes, Abiomed, and AngloGold Ashanti Slumped Today

Upbeat sentiment among investors helped push Wall Street higher on Monday with many looking forward to the lates t earnings release from Google s parent company Alphabet Even with weakness in crude oil and precious metals and a slight rise in bond yields stocks generally

Health Care Sector Update for 02/04/2019: ABMD,OMCL,BLRX,ABBV,BLK

Top Health Care StocksTop Health Care Stocks JNJ 1 24 JNJ 1 24 PFE 1 43 PFE 1 43 ABT 0 23 ABT 0 23 MRK 0 27 MRK 0 27 AMGN 0 84 AMGN 0 84 Health care stocks trimmed some of their prior declines Monday including a nearly 0 4 decline for the NYSE Health Care Index in afternoon

Monday Sector Laggards: Utilities, Healthcare

Looking at the sectors faring worst as of midday Monday shares of Utilities companies are underperforming other sectors showing a 0 2 loss Within the sector NiSource Inc Symbol NI and Edison International Symbol EIX are two large stocks that are lagging showing a loss of 2 1 and 1

Abiomed (ABMD) Upgraded to Buy: What Does It Mean for the Stock?

Abiomed ABMD could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank 2 Buy This upgrade is essentially a reflection of an upward trend in earnings estimates one of the most powerful forces impacting stock prices The sole determinant of the Zacks rating is

3 Reasons Why Growth Investors Shouldn't Overlook Abiomed (ABMD)

Investors seek growth stocks to capitalize on above average growth in financials that help these securities grab the market s attention and produce exceptional returns But finding a growth stock that can live up to its true potential can be a tough task By their very nature these stocks

ABIOMED (ABMD) Q3 Earnings Beat, Impella Maintains Momentum

ABIOMED Inc ABMD reported third quarter fiscal 2019 earnings of 97 cents per share which surpassed the Zacks Consensus Estimate of 94 cents The bottom line also skyrocketed 235 from the figure registered in the year ago quarter Revenues came in at 200 6 million missing the

Abiomed Raises Guidance After Another Strong Quarter

Abiomed NASDAQ ABMD a maker of temporary heart pumps reported its fiscal third quarter results on Thursday Sales continue to grow at a robust rate thanks to strong demand in both domestic and international markets Net income grew at a triple digit rate yet again

ABIOMED, Inc. (ABMD) Q3 2019 Earnings Conference Call Transcript

Image source The Motley Fool ABIOMED Inc NASDAQ ABMD Q3 2019 Earnings Conference Call Jan 31 2019 8 00 a m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks Operator Good

Abiomed (ABMD) Tops Q3 Earnings Estimates

Abiomed ABMD came out with quarterly earnings of 0 97 per share beating the Zacks Consensus Estimate of 0 94 per share This compares to earnings of 0 70 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings surprise of 3

Medical Products' Earnings Lineup for Jan 31: EW, BAX & More

The Medical Products 160 companies within the broader Medical 160 sector are likely to put up a superb show this earnings season Focus on research and development is a key growth strategy for companies in this space Currently these players are benefiting from R amp D innovation

Nokia (NOK) to Report Q4 Earnings: What's in the Cards?

Nokia Corporation NOK is scheduled to report fourth quarter 2018 financial results before the opening bell on Jan 31 In the las t report ed quarter the company delivered a positive earnings surprise of 16 7 The Finnish telecom equipment manufacturer is likely to report lower revenues